Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 70,000 shares at $14.63 ($1.0M) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $1.0M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 67,600 | $989K | 96.4% |
| 2 | $15.27 | 2,400 | $37K | 3.6% |
| Total | $14.65 avg | 70,000 | $1.0M | 100% |
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |